Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia? [2]

Leukemia and Lymphoma

Volumn 48, Issue 6, 2007, Pages 1219-1221

  Poulain, Stéphanie ^a   Benard, Caroline ^a   Daudignon, Agnès ^a   Le Baron, F ^a   Morel, Pierre ^b   Duthilleul, Patrick ^a  

^a Service d'Hématologie Immunologie Cytogénétique   (France)

^b Service d'Hematologie Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; PROTEIN KINASE ZAP 70;

AGED; AUTOIMMUNE HEMOLYTIC ANEMIA; B CELL LEUKEMIA; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LETTER; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 34347356476     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701286488     Document Type: Letter

References (15)

1. Chiorazzi, N., Rai, K. and Ferranini, M. (2005) Chronic lymphocytic leukaemia. N Eng J Med, 352, pp. 804-815.
2. Dighiero, G. (2005) CLL Biology and prognosis. Hematology Am Soc Hematol Educ Program, 3, pp. 278-284.
3. Montserrat, E. (2006) New prognostic markers in CLL. Hematology Am Soc Hematol Educ Program, 3, pp. 279-284.
4. Rosenwald, A., Alizadeh, A., Widhopf, G., Simon, R. and Davis, R. (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med, 194, pp. 1639-1647.
5. Orchard, J., Ibbotson, R., Best, G., Parker, A. and Oscier, D. (2005) ZAP-70 in B cell malignancies. Leuk Lymphoma, 46, pp. 1689-1698.
6. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D. and Rozman, M. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med, 348, pp. 1764-1775.
7. Durig, J., Nuckel, H., Cremer, M., Fuhrer, A., Halfmeyer, K. and Fandrey, J. (2003) ZAP-70 expression is a prognostic factor in chronic lymphocytic. Leukaemia, 17, pp. 2426-2434.
8. Rassenti, L., Huynh, L., Toy, T. L., Chen, L., Keating, M. and Gribben, J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med, 351, pp. 893-901.
9. Principe, M Del, Poeta, G Del, Buccisano, F., Maurillo, L., Venditti, A. and Zuchetto, A. (2006) Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukaemia. Blood, 108, pp. 853-861.
10. Shanafelt, T., Witzig, T., Fink, S., Jenkins, R., Paternoster, S. and Smoley, S. (2006) Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukaemia. J Clin Oncol, 24, pp. 4634-4661.
11. Chen, Z. and Aston, E. (2005) Loss of ZAP 70 and low molecular weight phosphotyrosine phosphatase occurs after therapy in a patient with B-chronic lymphocytic leukemia. Leukemia, 19, pp. 1503-1505.
12. Chaar, B., Grosso, L. and Petruska, P. (2006) Variability of ZAP 70 expression in a patient with CLL. Am J Hematology, 81, p. 645.
13. Schroers, R., Griesinger, F., Trumper, L., Haase, D., Kulle, B. and Klein-Hitpass, L. (2005) Combined analysis of ZAP70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia, 19, pp. 750-758.
14. Orchard, J., Ibbotson, R., Davis, Z., Wiestner, A., Rosenwald, A. and Thomas, P. (2004) ZAP70 expression and prognosis in chronic lymphocytic leukaemia. Lancet, 363, pp. 105-111.
15. Hamblin, T., Orchard, J., Ibbotson, R., Davis, Z., Thomas, P. and Stevenson, F. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood, 99, pp. 1023-1029.